Global Treatment Planning Software Market, By Software Type (Auto-Contouring Software, Multi-Modality Software, PET/CT Deformable Software, DICOM-RT Software), End User (Hospitals, Cancer Research Institute, Diagnostic and Treatment Centers) – Industry Trends and Forecast to 2029.
Treatment Planning Software Market Analysis and Size
The patient treatment programmes are altering due to the revolutionary developments in the healthcare industry brought about by the increasing penetration of information technology. The treatment planning software is emerging as the radiation therapy's for the fast use of technology. The demand for treatment planning software is rising due to the rising number of cancer patients worldwide.
Data Bridge Market Research analyses that the treatment planning software market which was USD 2.00 billion in 2021, would rocket up to USD 3.99 billion by 2029, and is expected to undergo a CAGR of 9.00% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Treatment Planning Software Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Software Type (Auto-Contouring Software, Multi-Modality Software, PET/CT Deformable Software, DICOM-RT Software), End User (Hospitals, Cancer Research Institute, Diagnostic and Treatment Centers)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
DOSIsoft SA (France), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), RaySearch Laboratories (Sweden), Elekta (Sweden), Brainlab AG (Germany), IBA Worldwide (Belgium), Accuray Incorporated (U.S.), VIEWRAY TECHNOLOGIES, INC. (U.S.), Varian Medical Systems, Inc. (U.K.), Institut Straumann AG (Switzerland), Nobel Biocare Services AG (Switzerland), CAMLOG Biotechnologies GmbH (U.S.), medentis medical GmbH (Germany), BEGO Medical GmbH (Germany), Dentsply Sirona. (U.S.), Zimmer Biomet (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Radiation therapy for cancer patients is administered with the aid of treatment planning software. It can control radiations such as photons, FFF beams, electrons, low-dose-rate external beams for brachytherapy, protons, and cobalt treatment. The software decreases inter-planner variability, shortens planning times, and enhances patient-centered plan quality.
Treatment Planning Software Market Dynamics
Drivers
- Rising need for cutting-edge and efficient cancer treatments
The main reasons propelling the treatment planning software market are the rising need for cutting-edge and efficient cancer treatments around the world, an increase in the number of cancer patients, and a sizeable expenditure budget of them. Additionally, the fact that the software offers advanced care with the aid of beam planning and automated calculations and is substantially more accurate, quick, and efficient also accelerates the market expansion in the forecast period of 2022 to 2029.
- Increase in cancer treatment
Another driver propelling the market is the growing acceptance of proton therapy, since these beams are increasingly favoured for cancer treatment. Medical and research institutions are implementing treatment planning software to lessen collateral tissue damage and the negative effects of radiation therapy to the patients, creating an opportunity for market players.
- Technological developments
The patient treatment programmes are altering with the ways that doctors give care due to the revolutionary developments in the healthcare industry brought by the increasing perception of information technology. The treatment planning software is emerging as the radiation therapy's beating for the fast use of technology. The demand for treatment planning software is rising due to the rising number of cancer patients worldwide.
Opportunities
- Increase in the number of research and development activities
The capacity of the software to regulate radiation beams such as protons, photons, FFF beams, electrons, low-dose-rate brachytherapy external beams, and cobalt therapy in cancer treatment is another factor driving up demand for treatment planning systems.
Restraints/Challenges
- High cost
On the other hand, high costs and a lack of skilled workforce to plan and operate the software are expected to obstruct the market growth. Also, less adoption rate in developing economies could be a challenge for the treatment planning software market in the above-mentioned forecast period.
This treatment planning software market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the treatment planning software market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 impact on Treatment Planning Software Market
COVID-19 has an positive impact on the treatment planning industry. Every industry has been impacted by the worldwide public health emergency known as COVID-19, and the long-term impacts are expected to have an influence on industry growth throughout the forecast period. TPS provides models for a variety of radiation sources and radiotherapy treatment apparatus.
Global Treatment Planning Software Market Scope
The treatment planning software market is segmented on the basis of type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Auto-Contouring Software
- Multi-Modality Software
- Pet/Ct Deformable Software
- Dicom-Rt Software
End User
- Hospitals
- Cancer Research Institute
- Diagnostic and Treatment Centers
Treatment planning software Market Regional Analysis/Insights
The treatment planning software market is analysed and market size insights and trends are provided by country, type and end-user as referenced above.
The countries covered in the treatment planning software market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates treatment planning software market because of higher presence of cancer patients as well as cancer treatment providing centers and institutes.
Asia-Pacific is estimated to grow in the forecast period of 2022-2029 due to growing adoption of radiation therapy for cancer treatment.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value cain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Treatment Planning Software Market Share Analysis
The treatment planning software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to treatment planning software market.
Some of the major players operating in the treatment planning software market are:
- DOSIsoft SA (France)
- Koninklijke Philips N.V. (Netherlands)
- MIM Software Inc. (U.S.)
- RaySearch Laboratories (Sweden)
- Elekta (Sweden)
- Brainlab AG (Germany)
- IBA Worldwide (Belgium)
- Accuray Incorporated (U.S.), VIEWRAY TECHNOLOGIES, INC. (U.S.)
- Varian Medical Systems, Inc. (U.K.)
- Institut Straumann AG (Switzerland)
- Nobel Biocare Services AG (Switzerland)
- CAMLOG Biotechnologies GmbH (U.S.)
- medentis medical GmbH (Germany)
- BEGO Medical GmbH (Germany)
- Dentsply Sirona. (U.S.)
- Zimmer Biomet (U.S.)
SKU-